The response to acute stress may be altered in Angelman syndrome (AS), a preclinical study suggests. In a mouse…
Lindsey Shapiro, PhD
Lindsey earned her PhD in neuroscience from Emory University in Atlanta, where she studied novel therapeutic strategies for treatment-resistant forms of epilepsy. She was awarded a fellowship from the American Epilepsy Society in 2019 for this research. Lindsey also previously worked as a postdoctoral researcher, studying the role of inflammation in epilepsy and Alzheimer’s disease.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Lindsey Shapiro, PhD
Organizations around the world will come together Feb. 15 to observe International Angelman Day (IAD), a global effort to…
A very large deletion on chromosome 15 — the largest yet reported — was identified as the underlying cause of…
People with Angelman syndrome (AS) can demonstrate an ability to comprehend verbal communication as accurately as typically developed children,…
A telehealth-based training program for parents of children with Angelman syndrome helped them in using naturalistic communication interventions (NCI), set…
Ultragenyx will continue clinical development of GTX-102, an investigational treatment for Angelman syndrome, after acquiring GeneTx Biotherapeutics…